Portola Pharmaceuticals Inc (USD)
PTLA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range26.09 | 27.15
52-Wk Range14.81 | 37.95
Last Close26.31
Mkt Cap (m)2,047.42
Dividend yield-
ISINUS7370101088
Volume703,938
Exchange VenueNAS

Company Profile

Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.

Key Information
Price/Earning-
Price/Book9.62
Price/Sales17.60
P/CF-
Rev Growth (3 year avg)49.25
EPS Growth (3 year avg)-
Operating Margin % -860.50
Net Margin %-872.72
Return on Equity-160.92
Debt/Equity2.44

Legal Documents

Prospectus
en 14/08/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)111012362340
Operating Income (m)-84-138-227-270-273-345
Net Income (m)-83-137-227-269-286-350
Basic EPS-3.65-3.19-4.36-4.76-4.81-5.31
Avg. Diluted Shares Outstanding (m)234352566066
Balance Sheet
USD201320142015201620172018
Current Assets (m)273315466329478353
Non Current Assets (m)5310137159433
Total Assets (m)326416503343572386
Current Liabilities (m)264151668169
Total Liabilities (m)------
Total Equity (m)29634842719134788
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-64-101-207-196-225-326
Capital Expenditure (m)-1-2-5-2-6-3
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
26.31
Last Price